{"podcast":{"title":"Primary Care Update","slug":"primary-care-update-1000928","podcast_index_feed_id":1000928,"rss_url":"https://anchor.fm/s/5693a5c/podcast/rss","website_url":"https://podcasters.spotify.com/pod/show/primary-care-update","image_url":"https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded_nologo/807823/807823-1535146710716-0fbae5650ccb6.jpg","author":"Mark Ebell","episode_count":207,"summary":"Four healthily skeptical primary care physicians discuss the latest in primary care medicine. Join Essential Evidence Editor Mark Ebell MD, Rush University's Kate Rowland MD, MSU Professor of Medicine Gary Ferenchick MD, and POEMs co-founder Henry Barry MD, MS for this fast-paced weekly update on evidence-based primary care.","last_synced_at":null,"page_url":"https://stenobird.com/podcast/primary-care-update-1000928"},"episode":{"title":"Episode 198: Tirzepatide, using Beers, stent for carotid stenosis, and high dose flu vaccine","slug":"episode-198-tirzepatide-using-beers-stent-for-carotid-stenosis-and-high-dose-flu-vaccine","published_at":"2026-01-22T19:50:20+00:00","page_url":"https://stenobird.com/podcast/primary-care-update-1000928/episode-198-tirzepatide-using-beers-stent-for-carotid-stenosis-and-high-dose-flu-vaccine","show_page_url":"https://stenobird.com/podcast/primary-care-update-1000928","url":"https://podcasters.spotify.com/pod/show/primary-care-update/episodes/Episode-198-Tirzepatide--using-Beers--stent-for-carotid-stenosis--and-high-dose-flu-vaccine-e3e1t1h","audio_url":"https://anchor.fm/s/5693a5c/podcast/play/114405873/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-0-22%2F8b8c67b9-df27-b0f0-1050-8f9dfba326c6.mp3","summary":"Join Mark, Kate, Henry and Gary as they discuss 4 new POEMs (Patient Oriented Evidence that Matters, studies with the potential to change practice): a summary of the evidence on tirzepatide (Zepbound) for weight loss, using the Beers list with your patients, high vs standard dose flu vaccine and the risk of hospitalization, and whether stent or endarterectomy are better than maximal medical therapy for patients with asymptomatic carotid stensosis. Here are the links: Essential Evidence Plus: www.essentialevidenceplus.com Tirzepatide systematic review: https://pubmed.ncbi.nlm.nih.gov/41015578/ Tirzepatide vs dulaglutide: https://pubmed.ncbi.nlm.nih.gov/41406444/ Applying the Beers list: https://pubmed.ncbi.nlm.nih.gov/40697073/ High vs standard dose flu vaccine: https://pubmed.ncbi.nlm.nih.gov/41115437/ Another high dose flu trial: https://pubmed.ncbi.nlm.nih.gov/39230284/ Asymptomatic carotid stenosis treatment: https://pubmed.ncbi.nlm.nih.gov/41269206/","meta_description":"Join Mark, Kate, Henry and Gary as they discuss 4 new POEMs (Patient Oriented Evidence that Matters, studies with the potential to change practice): a sum…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1644,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/primary-care-update-1000928/episodes/episode-198-tirzepatide-using-beers-stent-for-carotid-stenosis-and-high-dose-flu-vaccine/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/primary-care-update-1000928/episode-198-tirzepatide-using-beers-stent-for-carotid-stenosis-and-high-dose-flu-vaccine.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}